Osmotic Laxative — Bowel Preparation / Constipation
Pregnancy: Considered safe in pregnancy for constipation; avoid large-volume bowel prep unless clearly indicated
Macrogol (Polyethylene Glycol)
Brand names: Klean-Prep, Moviprep, Laxido
Adult dose
Dose: Bowel prep: 2-4 litres over 4-6 hours (Klean-Prep/Moviprep). Constipation: 1-3 sachets daily (Laxido)
Route: Oral
Frequency: Bowel prep: single course day before procedure; constipation: once to three times daily
Max: 4 litres for bowel preparation
Moviprep (split-dose 1 L + 1 L): half evening before, half morning of procedure — superior colonoscopy quality. Klean-Prep: 4 litres day before. Laxido: 1-3 sachets dissolved in 125 mL water each
Paediatric dose
Dose: 1-1.5 g/kg/day (faecal impaction: up to 4 days); 0.4 g/kg/day (maintenance) g/day/kg
Route: Oral
Frequency: Once daily (maintenance); divided doses (disimpaction)
Max: 8 sachets/day (disimpaction); 4 sachets/day (maintenance)
NICE NG90: macrogol first-line for childhood constipation and faecal impaction. Child 2-11 years: 2-4 sachets/day (disimpaction); 1-4 sachets/day (maintenance)
Dose adjustments
Renal
Use with caution in moderate-severe renal impairment — electrolyte disturbances
Hepatic
No specific adjustment
Paediatric weight-based calculator
NICE NG90: macrogol first-line for childhood constipation and faecal impaction. Child 2-11 years: 2-4 sachets/day (disimpaction); 1-4 sachets/day (maintenance)
Clinical pearls
- Macrogol is an inert polymer that retains water in the bowel by osmosis without being absorbed or metabolised — electrolyte-balanced formulations (Klean-Prep, Moviprep) include sodium, potassium, and bicarbonate to minimise disturbances
- Moviprep split-dose: recommended by BSG — better bowel cleanliness scores than day-before full preparation; important for morning colonoscopy procedures
- Post-operative ileus: macrogol plus early mobilisation and oral intake are cornerstones of management — avoid stimulant laxatives until bowel sounds return
- Paediatric faecal impaction (NICE NG90): macrogol escalating dose disimpaction preferred over manual evacuation — start 2 sachets/day and increase by 2 sachets every 2 days to max 8
- Aspiration risk during large-volume prep: position patient upright; contraindicated if unable to swallow safely
Contraindications
- Intestinal obstruction or perforation
- Ileus
- Toxic megacolon
- Severe inflammatory bowel disease
Side effects
- Nausea, bloating, abdominal cramps (large volume prep)
- Electrolyte disturbances (hyponatraemia — particularly with large volumes)
- Allergic reactions (rare — to additives in formulation)
- Pulmonary aspiration (if vomiting during prep)
Interactions
- Drugs with narrow therapeutic window (absorption reduced by rapid GI transit during preparation)
Monitoring
- Electrolytes (bowel prep — hyponatraemia risk in elderly)
- Fluid balance
- Bowel output (prep adequacy)
Reference: BNFc; BNF 90; Moviprep SPC; BSG Bowel Preparation Guidelines; NICE NG90 (Childhood Constipation). Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- Osmol Gap · Renal / Metabolic
- Harvey-Bradshaw Index for Crohn's Disease · Inflammatory Bowel Disease
- Mayo Score for Ulcerative Colitis Activity · Inflammatory Bowel Disease
- Rome IV Criteria for Irritable Bowel Syndrome · Functional GI
- Crohn's Disease Activity Index (CDAI) · Inflammatory Bowel Disease
- Truelove and Witts Severity Index for Ulcerative Colitis · Inflammatory Bowel Disease
Pathways
- Major Trauma — Primary Survey (ATLS) · ATLS 10th Edition; JRCALC; NICE NG39
- Major Haemorrhage / Massive Transfusion · BCSH; RCOA; RCEM; RCS — BCSH Guidelines
- Lower Gastrointestinal Bleed · NICE; BSG; ACPGBI — Commissioning Guide
- Acute Pancreatitis · NICE; IAP/APA; ACPGBI — CG104
- Faecal Peritonitis · ASGBI; RCS — Best Practice
- Acute Compartment Syndrome · BAPRAS; BOA; RCS — Best Practice